Luxfer Holdings PLC (NYSE:LXFR – Free Report) – Investment analysts at Sidoti Csr decreased their Q2 2025 EPS estimates for Luxfer in a research note issued to investors on Thursday, May 1st. Sidoti Csr analyst S. Ferazani now forecasts that the industrial products company will earn $0.21 per share for the quarter, down from their prior estimate of $0.24. The consensus estimate for Luxfer’s current full-year earnings is $0.85 per share. Sidoti Csr also issued estimates for Luxfer’s Q2 2026 earnings at $0.28 EPS and Q3 2026 earnings at $0.28 EPS.
Separately, StockNews.com raised shares of Luxfer from a “buy” rating to a “strong-buy” rating in a report on Friday, February 21st.
Luxfer Stock Up 1.4 %
Shares of Luxfer stock opened at $11.21 on Monday. Luxfer has a 12-month low of $9.41 and a 12-month high of $15.64. The stock has a market capitalization of $305.33 million, a P/E ratio of 33.97, a PEG ratio of 1.85 and a beta of 1.09. The company has a quick ratio of 1.14, a current ratio of 2.17 and a debt-to-equity ratio of 0.29. The stock has a 50 day moving average price of $11.08 and a two-hundred day moving average price of $12.86.
Luxfer (NYSE:LXFR – Get Free Report) last released its quarterly earnings results on Tuesday, February 25th. The industrial products company reported $0.25 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.22 by $0.03. Luxfer had a return on equity of 9.26% and a net margin of 2.37%. The company had revenue of $103.40 million during the quarter, compared to the consensus estimate of $89.50 million.
Hedge Funds Weigh In On Luxfer
A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Bank of America Corp DE raised its position in shares of Luxfer by 48.3% during the fourth quarter. Bank of America Corp DE now owns 1,854,220 shares of the industrial products company’s stock valued at $24,272,000 after buying an additional 603,954 shares during the last quarter. Hillsdale Investment Management Inc. raised its holdings in Luxfer by 2,131.4% in the 4th quarter. Hillsdale Investment Management Inc. now owns 312,400 shares of the industrial products company’s stock valued at $4,089,000 after acquiring an additional 298,400 shares in the last quarter. Royce & Associates LP grew its holdings in shares of Luxfer by 20.4% during the 4th quarter. Royce & Associates LP now owns 1,624,061 shares of the industrial products company’s stock worth $21,259,000 after purchasing an additional 275,669 shares in the last quarter. Millennium Management LLC bought a new stake in shares of Luxfer during the fourth quarter valued at approximately $3,308,000. Finally, JPMorgan Chase & Co. boosted its stake in Luxfer by 441.5% during the fourth quarter. JPMorgan Chase & Co. now owns 150,150 shares of the industrial products company’s stock worth $1,965,000 after buying an additional 122,423 shares in the last quarter. Institutional investors own 90.82% of the company’s stock.
Luxfer Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, May 7th. Stockholders of record on Friday, April 18th will be issued a dividend of $0.13 per share. The ex-dividend date of this dividend is Thursday, April 17th. This represents a $0.52 dividend on an annualized basis and a dividend yield of 4.64%. Luxfer’s dividend payout ratio (DPR) is presently 66.67%.
Luxfer Company Profile
Luxfer Holdings PLC, together with its subsidiaries, designs, manufactures, and supplies high-performance materials, components, and high-pressure gas containment devices for defense and first response, healthcare, transportation, and general industrial applications. The company operates through three segments: Elektron, Gas Cylinders, and graphic Arts.
Read More
- Five stocks we like better than Luxfer
- Using the MarketBeat Stock Split Calculator
- 3 Mid-Cap Medical Stocks Outperforming the Market
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- The Top-Ranked Insider Buys From April by Market Cap
- 3 Fintech Stocks With Good 2021 Prospects
- Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?
Receive News & Ratings for Luxfer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Luxfer and related companies with MarketBeat.com's FREE daily email newsletter.